BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EB
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) has issued a Broad Agency Announcement (BAA) for Research and Development in support of JPM Medical and JPL Enabling Biotechnologies. This BAA seeks innovative science to develop medical countermeasures and enabling biotechnologies against CBRN threats. Pre-proposals can be submitted at any time while the announcement is active, with a response period extending until January 1, 2031.
Purpose & Scope
This BAA aims to identify the best available science from educational institutions, nonprofit organizations, and private industry for research and development efforts. The focus is on developing medical CBRN countermeasures and enabling biotechnologies. The BAA contemplates various award types, including procurement contracts, grants, cooperative agreements, and Other Transaction Agreements (OTAs).
Key Research Areas / Requirements
The JPEO-CBRND is specifically interested in studies related to novel solutions and improved methods for more rapid and efficient development of medical countermeasures. This includes enabling technologies, life cycle bioinformatics, and improved logistics tracking. Proposals based on data from experiments using specific CBRN warfare agents to demonstrate safety, efficacy, or mode of action are not of interest. For advanced development, efforts should generally be limited to Technology Readiness Level (TRL) 4.
Contract & Submission Details
- Opportunity Type: Broad Agency Announcement (BAA)
- Awards Contemplated: Procurement Contracts, Grants, Cooperative Agreements, TIAs, OTAs
- Set-Aside: None (Open to all eligible sources)
- Response Period: Open until January 1, 2031
- Submission: Pre-proposals (white papers) are encouraged and can be submitted at any time. Full proposals will be solicited via a Request for Full Proposal (RFFP) if a pre-proposal is accepted.
- Published: March 24, 2026
Evaluation Criteria
Evaluation factors for proposals include: Technical Merit, Military and Program Relevance, Funds Availability, Technology Readiness Level (TRL), Project Objectives, Regulatory Compliance, Support of other U.S. Government requirements, Key Personnel Qualifications, Facilities, Budget/Cost, and Past Performance. Award decisions are expected within 180 days after submission.
Eligibility & Contacts
This opportunity is open to all eligible sources, including educational institutions, nonprofit organizations, and private industry.
- Administrative Questions: usarmy.detrick.dod-jpeo-cbrnd.mbx.baa@army.mil, ATTN: CBRND BAA 22-01
- Technical Questions: Potential Offerors are encouraged to discuss proposal ideas with the JPMO technical contacts listed in Section VII (B) of the BAA.
- Primary Contact: Joseph McCaffery (joseph.w.mccaffery2.civ@army.mil)
- Secondary Contact: Keith Pereira (keith.d.pereira.civ@army.mil)